CDIO
HEALTHCARECardio Diagnostics Holdings Inc
$1.82-0.01 (-0.55%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving CDIO Today?
No stock-specific AI insight has been generated for CDIO yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.97$7.91
$1.82
Fundamentals
Market Cap$5M
P/E Ratio—
EPS$-3.71
Dividend Yield—
Dividend / Share—
ROE-0.8%
Profit Margin—
Debt / Equity—
Trading
Volume56K
Avg Volume (10D)—
Shares Outstanding3.0M
CDIO News
20 articles- Cardio Diagnostics Holdings (CDIO) Advancing Early Detection, Tackling Heart Disease Through AI and Biomarker InsightsYahoo Finance·May 1, 2026
- Cardio Diagnostics Holdings (CDIO) Advancing AI Solutions for Cardiovascular Disease Detection and ManagementYahoo Finance·Apr 27, 2026
- Why Cardio Diagnostics Holdings (CDIO) is 'One to Watch'Yahoo Finance·Apr 20, 2026
- IBN Initiates Coverage of Cardio Diagnostics Holdings Inc.Yahoo Finance·Apr 8, 2026
- Cardio Diagnostics Holdings (CDIO) Is 'One to Watch'Yahoo Finance·Apr 1, 2026
- CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, February 19, 2026Yahoo Finance·Feb 18, 2026
- Cardio Diagnostics, Aimil Ltd. and Dr. Lal PathLabs Limited Partner to Launch the PrecisionCHD™ Test in IndiaYahoo Finance·Jan 7, 2026
- Cardio Diagnostics Holdings, Inc. and Southdale YMCA Announce New Heart Health Partnership to Serve the Edina, Minnesota CommunityYahoo Finance·Jan 6, 2026
- Is DXC (DXC) Centralizing Digital And AI Leadership To Reframe Its Long-Term Competitiveness Story?Yahoo Finance·Dec 11, 2025
- DXC Appoints Russell Jukes as Chief Digital Information Officer to Strengthen Unified Digital StrategyYahoo Finance·Dec 8, 2025
- Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)Yahoo Finance·Dec 3, 2025
- Cardio Diagnostics Holdings, Inc. to Present Data Demonstrating PrecisionCHD’s Ability to Detect INOCA and MINOCA at the American Heart Association Scientific SessionsYahoo Finance·Nov 5, 2025
- Cardio Diagnostics Holdings, Inc. and YMCA of East Tennessee Partner to Bring Heart Health Education and Advanced Testing to East Tennessee CommunityYahoo Finance·Oct 28, 2025
- Cardio Diagnostics Holdings, Inc. Expands Provider Network, Adding 15 New Provider Organizations From Across the United StatesYahoo Finance·Oct 21, 2025
- e.l.f. Beauty’s CDIO says she’s responsible for AI’s foundation, but that these tools aren’t an IT mandateYahoo Finance·Sep 10, 2025
- Cardio Diagnostics Holdings Second Quarter 2025 Earnings: US$0.97 loss per share (vs US$1.71 loss in 2Q 2024)Yahoo Finance·Aug 16, 2025
- Cardio Diagnostics Receives Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)Yahoo Finance·Jul 22, 2025
- Cardio Diagnostics Enters Into an Agreement with AGEPHA Pharma to Advance Precision Assessment and Management of Inflammation Associated with Coronary Heart DiseaseYahoo Finance·Jul 8, 2025
- Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection TechnologyYahoo Finance·Jun 10, 2025
- Cardio Diagnostics Holdings, Inc. (CDIO): A Bull Case TheoryYahoo Finance·Jun 9, 2025
All 20 articles loaded
Price Data
Open$1.70
Previous Close$1.83
Day High$1.94
Day Low$1.70
52 Week High$7.91
52 Week Low$0.97
52-Week Range
$0.97$7.91
$1.82
Fundamentals
Market Cap$5M
P/E Ratio—
EPS$-3.71
Dividend Yield—
Dividend / Share—
ROE-0.8%
Profit Margin—
Debt / Equity—
Trading
Volume56K
Avg Volume (10D)—
Shares Outstanding3.0M
About Cardio Diagnostics Holdings Inc
Cardio Diagnostics Holdings Inc (CDIO) is an innovative biotechnology firm dedicated to transforming cardiovascular health through advanced diagnostic solutions. By utilizing state-of-the-art technologies, CDIO empowers healthcare providers with essential tools for the precise assessment and management of cardiovascular diseases, significantly improving patient outcomes. The company’s strong focus on personalized medicine positions it for robust growth and makes it an attractive prospect for institutional investors looking to capitalize on the advancements in the rapidly evolving healthcare landscape.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—